ArticleFrontiers in pharmacology2026

Biomimetic astragaloside-IV-loaded mesoporous silica nanoparticles for treatment of dilated cardiomyopathy.

Chenghua Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.